Ramni® (Tablets) Instructions for Use
Marketing Authorization Holder
Tatkhimpharmpreparaty, JSC (Russia)
ATC Code
A02AX (Antacids in combination with other agents)
Active Substances
Calcium carbonate (Ph.Eur.)
Magnesium carbonate (Ph.Eur.)
Dosage Form
| Ramni® | Chewable tablets: 6, 10, 12, 20 or 24 pcs. |
Dosage Form, Packaging, and Composition
Chewable tablets white or almost white with a creamy tint, round, flat-cylindrical; with a reinforced bevel, without a score line, with an orange odor; slight marbling and minor inclusions are allowed.
| 1 tab. | |
| Calcium Carbonate | 680 mg |
| Magnesium carbonate (Basic magnesium carbonate) | 80 mg |
Excipients: mannitol, povidone (kollidon 90F), sucrose, orange flavor, sodium stearyl fumarate, talc.
6 pcs. – contour cell packs (1) – cardboard packs.
6 pcs. – contour cell packs (2) – cardboard packs.
6 pcs. – contour cell packs (4) – cardboard packs.
10 pcs. – contour cell packs (1) – cardboard packs.
10 pcs. – contour cell packs (2) – cardboard packs.
Clinical-Pharmacological Group
Antacid drug
Pharmacotherapeutic Group
Acid-related disorder treatment agents; antacids; antacids, other combinations
Pharmacological Action
Antacid drug. Contains Calcium Carbonate and Magnesium carbonate, which provide rapid and prolonged neutralization of excess hydrochloric acid of gastric juice, thereby exerting a protective effect on the gastric mucosa.
Achievement of the therapeutic effect within 3-5 minutes is due to the good solubility of the tablets and the high calcium content.
Pharmacokinetics
As a result of the interaction of the drug with gastric juice, soluble salts of calcium and magnesium are formed in the stomach. The degree of absorption of calcium and magnesium from these compounds depends on the dose of the drug. Maximum absorption is 10% for calcium and 15-20% for magnesium.
A small amount of absorbed calcium and magnesium is excreted by the kidneys. In the intestine, insoluble compounds are formed from soluble salts, which are excreted in the feces.
Pharmacokinetics in special clinical cases
In case of impaired renal function, the concentration of calcium and magnesium in plasma may increase.
Indications
Symptoms associated with increased acidity of gastric juice and reflux esophagitis: heartburn, sour belching, occasional stomach pain, feeling of fullness or heaviness in the epigastric region, dyspepsia (including those caused by dietary errors, medication intake, alcohol, coffee, or nicotine abuse); dyspepsia of pregnancy.
ICD codes
| ICD-10 code | Indication |
| K21.0 | Gastro-esophageal reflux disease with esophagitis |
| K30 | Functional dyspepsia (digestive disorder) |
| K31.8 | Other specified diseases of stomach and duodenum |
| O99.6 | Diseases of the digestive system complicating pregnancy, childbirth and the puerperium |
| R10.1 | Pain localized to the upper abdomen |
| R12 | Heartburn |
| R14 | Flatulence and related conditions (including abdominal bloating, belching) |
| ICD-11 code | Indication |
| DA22.Z | Gastro-esophageal reflux disease, unspecified |
| DA24.Z | Unspecified esophagitis |
| DA40.2 | Volvulus of stomach |
| DA41.0Z | Unspecified disorder of stomach motility |
| DA41.2 | Acid hyper secretion |
| DA41.3 | Achlorhydria |
| DA43.1 | Angiodysplasia of stomach |
| DA43.2 | Arteriovenous malformation of the stomach |
| DA43.3 | Gastropathy in portal hypertension |
| DA43.4 | Diffuse gastric vascular ectasia |
| DA4Y | Other specified diseases of the stomach |
| DA50.3 | Deformation of duodenum, acquired |
| DA52.1 | Angiodysplasia of duodenum |
| DA52.2 | Arteriovenous malformation of duodenum |
| DA52.Y | Other specified vascular diseases of duodenum |
| DA7Z | Diseases of stomach or duodenum, unspecified |
| DD90.0 | Globus sensation |
| DD90.1 | Functional dysphagia |
| DD90.3 | Functional dyspepsia |
| DD90.Z | Functional disorders of esophagus or gastroduodenal system, unspecified |
| JB64.6 | Diseases of the digestive system complicating pregnancy, childbirth, or the puerperium |
| MD81.10 | Pain localized in the upper abdomen |
| MD95 | Heartburn |
| ME08 | Flatulence and related conditions |
| ME24.3Y | Other specified perforation in the area of the gastrointestinal tract |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Take the drug orally.
Chew 1-2 tablets thoroughly when symptoms appear.
Alternatively, hold the tablets in the mouth until they are completely dissolved.
Repeat the dose after 2 hours if symptoms persist.
Adhere strictly to the maximum daily dose of 11 tablets.
Do not exceed this limit to avoid adverse effects.
For children under 12 years of age, the use of this drug is contraindicated.
For patients with renal impairment, avoid long-term use at high doses.
Take other medications 1-2 hours before or after this antacid to prevent interactions.
Monitor serum calcium levels if using concurrently with thiazide diuretics.
Adverse Reactions
Allergic reactions very rarely – rash, angioedema, anaphylactic reactions.
When the recommended doses are followed, the drug is well tolerated.
Contraindications
Severe renal failure; hypercalcemia; hypophosphatemia; nephrocalcinosis; children under 12 years of age; sucrase/isomaltase deficiency, fructose intolerance, glucose-galactose malabsorption syndrome; hypersensitivity to the components of the drug.
Use in Pregnancy and Lactation
When used in recommended doses, the drug does not pose a danger to the fetus or child.
Use in Renal Impairment
Contraindicated in severe renal failure, nephrocalcinosis.
Pediatric Use
Contraindicated in children under 12 years of age.
Special Precautions
When prescribing the drug to patients with impaired renal function, the concentration of magnesium, phosphorus and calcium in the blood serum should be regularly monitored.
Patients with impaired renal function are not recommended to take the drug for a long time in high doses.
Use of the drug in high doses may increase the risk of kidney stones.
Effect on the ability to drive vehicles and machinery
The use of the drug does not affect the ability to perform potentially hazardous activities that require increased concentration and speed of psychomotor reactions.
Drug Interactions
A change in the acidity of gastric juice caused by taking antacids may lead to a decrease in the rate and extent of absorption of other drugs taken simultaneously, therefore, medications should be taken 1-2 hours before or after taking antacids.
With simultaneous use, antacids reduce the absorption of antibiotics of the tetracycline group, fluoroquinolones, cardiac glycosides, levothyroxine, iron preparations, phosphates, fluorides.
With simultaneous use with thiazide diuretics, the concentration of calcium in the blood serum should be regularly monitored.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer
Arbidol, capsules 100mg, 40pcs
Noopept, pills 10mg, 50pcs
Fenotropil pills 100mg, 60pcs
Picamilon pills 50mg, 60pcs
Actovegin pills 200mg, 50pcs
Belosalic, ointment, 30g
Phenibut-Vertex pills 250mg, 20pcs
Nootropil pills 800mg, 30pcs
Daivobet, ointment, 30g
Ingavirin capsules 90mg, 10pcs
Kagocel pills 12mg, 30pcs
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Cortexin, 10mg, 5ml, 10pcs 